ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 247

$898K Total Retail Price of All Prescriptions

Rank: 5 out of 247

456 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 12,489 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 620 548 1 1
OMEPRAZOLE 581 529 2 4
METOPROLOL TARTRATE 413 360 3 7
LISINOPRIL 394 349 4 2
ATORVASTATIN CALCIUM 393 375 5 8
FUROSEMIDE 383 356 6 5
LEVOTHYROXINE SODIUM 348 325 7 3
METOPROLOL SUCCINATE 320 290 8 14
LOSARTAN POTASSIUM 319 290 9 15
ATENOLOL 318 280 10 10
AMLODIPINE BESYLATE 295 288 11 6
WARFARIN SODIUM 250 245 12 13
POTASSIUM CHLORIDE 249 244 13 36
HYDROCODONE-ACETAMINOPHEN 241 161 S3 14 11
SPIRONOLACTONE 233 208 15 53
HYDROCHLOROTHIAZIDE 215 205 16 9
ALLOPURINOL 173 153 17 33
SERTRALINE HCL 168 160 18 16
ISOSORBIDE MONONITRATE ER 162 129 19 40
DIGOXIN 159 158 20 83
MIRTAZAPINE 157 118 21 46
TAMSULOSIN HCL 149 148 22 31
PREDNISONE 135 118 23 21
FAMOTIDINE 134 132 24 66
FINASTERIDE 131 113 25 73
FENOFIBRATE 130 105 26 75
RANITIDINE HCL 130 122 26 34
LANTUS 125 103 28 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 121 29 51
LOSARTAN-HYDROCHLOROTHIAZIDE 118 118 30 128
LOVASTATIN 115 112 31 22
HUMALOG 115 106 31 78
NEXIUM 113 52 33 42
HYDRALAZINE HCL 112 100 34 99
SOTALOL 111 111 35 130
DOXAZOSIN MESYLATE 111 94 35 57
ALENDRONATE SODIUM 105 94 37 32
CLOPIDOGREL 102 87 38 70
DIOVAN HCT 101 94 39 96
ZETIA 101 77 39 62
DONEPEZIL HCL 99 97 41 35
GLIPIZIDE 96 82 42 43
NITROSTAT 96 82 42 111
QUETIAPINE FUMARATE 94 92 44 84
CYCLOBENZAPRINE HCL 91 46 R 45 54
METFORMIN HCL 87 79 46 12
GABAPENTIN 85 72 47 17
POLYETHYLENE GLYCOL 3350 84 77 48 77
PANTOPRAZOLE SODIUM 82 76 49 19
SUCRALFATE 81 70 50 131
CITALOPRAM HBR 79 63 51 20
CARVEDILOL 78 78 52 59
GLYBURIDE 77 64 R 53 41
LIPITOR 77 72 53 50
NAMENDA 73 73 55 47
PLAVIX 73 65 55 106
CRESTOR 70 47 57 30
PAROXETINE HCL 69 69 58 45
PRAVASTATIN SODIUM 69 63 58 23
KLOR-CON 10 68 58 60 103
INSULIN SYRINGE 67 46 61 68
FLUOXETINE HCL 67 50 61 49
NOVOLOG 59 50 63 99
FLUOCINONIDE 59 55 63 215
PROAIR HFA 58 37 65 29
LACTULOSE 57 57 66 147
NITROGLYCERIN PATCH 56 41 67 137
ISOSORBIDE DINITRATE 54 43 68 219
GLIPIZIDE XL 52 36 69 146
DIOVAN 50 48 70 38
CIPROFLOXACIN HCL 50 47 70 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.